Cargando…

Epidemiology, Disease Burden, and Treatment Strategies of Chronic Hepatitis C Virus Infections in Saudi Arabia in the New Treatment Paradigm Shift

BACKGROUND/AIMS: Around 101,000 individuals are estimated to be viremic for chronic hepatitis C virus (HCV) in the Kingdom of Saudi Arabia (KSA) in 2014; however, only about 20% have been diagnosed. We aim to assess baseline epidemiology, disease burden, and evaluate strategies to eliminate HCV in K...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aljumah, Abdulrahman A., Abaalkhail, Faisal, Al-Ashgar, Hamad, Assiri, Abdullah, Babatin, Mohamed, Al Faleh, Faleh, Alghamdi, Abdullah, Al-Hakeem, Raafat, Hashim, Almoataz, Alqutub, Adel, Razavi, Homie, Sanai, Faisal M., Al-Swat, Khalid, Schmelzer, Jonathan, Altraif, Ibrahim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Special Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991197/ https://www.ncbi.nlm.nih.gov/pubmed/27488321 http://dx.doi.org/10.4103/1319-3767.187609

Ejemplares similares

SASLT Position Statement on the Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection
por: Alghamdi, Abdullah S., et al.
Publicado: (2015)

SASLT Guidelines: Update in Treatment of Hepatitis C Virus Infection
por: Alghamdi, Abdullah S., et al.
Publicado: (2016)

Hepatitis B care pathway in Saudi Arabia: Current situation, gaps and actions
por: Aljumah, Abdulrahman A., et al.
Publicado: (2019)

Nonalcoholic fatty liver disease burden – Saudi Arabia and United Arab Emirates, 2017–2030
por: Alswat, Khalid, et al.
Publicado: (2018)

Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B
por: Sanai, Faisal M., et al.
Publicado: (2017)

SASLT Practice Guidelines for the Management of Hepatitis C Virus Infection: Summary of Recommendations
por: Alghamdi, Abdullah S., et al.
Publicado: (2012)

SASLT Practice Guidelines: Management of Hepatitis C Virus Infection
por: Alghamdi, Abdullah S., et al.
Publicado: (2012)

Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients
por: Babatin, Mohammed A., et al.
Publicado: (2019)

Epidemiology of Viral Hepatitis in Saudi Arabia: Are We Off the Hook?
por: Abdo, Ayman A., et al.
Publicado: (2012)

Greater prevalence of comorbidities with increasing age: Cross-sectional analysis of chronic hepatitis B patients in Saudi Arabia
por: Sanai, Faisal M., et al.
Publicado: (2019)

SASLT practice guidelines for the management of Hepatitis B virus – An update
por: Abaalkhail, Faisal A., et al.
Publicado: (2021)

IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection
por: Abdo, Ayman A., et al.
Publicado: (2013)

Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry
por: Alswat, Khalid, et al.
Publicado: (2021)

Efficacy of peginterferon α-2a and predictors of response in HBeAg-negative, genotype D-naive patients
por: Al-Ashgar, Hamad I., et al.
Publicado: (2011)

Validation of three noninvasive laboratory variables to predict significant fibrosis and cirrhosis in patients with chronic hepatitis C in Saudi Arabia
por: Abdo, Ayman A., et al.
Publicado: (2007)

Saudi Association for the Study of Liver Diseases and Transplantation position statement on liver transplantation during the COVID-19 pandemic
por: Al-Judaibi, Bandar, et al.
Publicado: (2020)

Saudi Guidelines for the Diagnosis and Management of Hepatocellular Carcinoma: Technical Review and Practice Guidelines: Created and endorsed by the Saudi Association for the Study of Liver Diseases and Transplantation and the Saudi Oncology Society
por: Abdo, Ayman A., et al.
Publicado: (2012)

Public awareness of diabetes complications and its effect on treatment compliance in Asir region, Saudi Arabia
por: Alhammadi, Nouf Ahmed, et al.
Publicado: (2022)

Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma
por: Alqahtani, Saleh A., et al.
Publicado: (2020)

Hepatitis C Genotype 4: Genotypic Diversity, Epidemiological Profile, and Clinical Relevance of Subtypes in Saudi Arabia
por: Al Ashgar, Hamad I, et al.
Publicado: (2013)

Role of Single Nucleotide Polymorphisms of KIF1B Gene in HBV-Associated Viral Hepatitis
por: Al-Qahtani, Ahmed, et al.
Publicado: (2012)

Hepatitis C virus core protein substitutions affect the response to pegylated-interferon and ribavirin therapy
por: Alhamlan, Fatimah S, et al.
Publicado: (2014)

Risk Factors of Arm Lymphedema Following Breast Reconstruction – An Updated Meta-Analysis
por: Alghamdi, Abdulrahman, et al.
Publicado: (2023)

Management of nonalcoholic fatty liver disease in the Middle East
por: Sanai, Faisal M, et al.
Publicado: (2020)

Presentation, Diagnosis and Outcome of Predominantly Hepatic Wilson's Disease in Adult Saudi Patients: A Single Centre Experience
por: Altraif, Ibrahim, et al.
Publicado: (2012)

Effect of Interferon Treatment on Hearing of Patients with Chronic Hepatitis C
por: Hagr, Abdulrahman, et al.
Publicado: (2011)

Sa1390: THE EFFICACY OF ELBASVIR/GRAZOPREVIR FIXED-DOSE COMBINATION FOR 8 WEEKS IN HCV TREATMENT AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN TREATMENT-NAIVE, NON-CIRRHOTIC, GENOTYPE 4-INFECTED PATIENTS (ELEGANT-4)
por: AlEid, Ahmad, et al.
Publicado: (2022)

Assessment of knowledge, accessibility, and adherence to the use of personal protective equipment and standard preventive practices among healthcare workers during the COVID-19 pandemic
por: Abdulrahman Yusuf, Khalifa, et al.
Publicado: (2023)

Hepatitis C Position Statement: Taking a Stand and Standing by it
por: Sanai, Faisal M., et al.
Publicado: (2015)

Expression of Concern: Fahr Disease: A Rare Cause of First-Time Seizure in the Emergency Department
por: Aldawsari, Faleh M, et al.
Publicado: (2022)

Fahr Disease: A Rare Cause of First-Time Seizure in the Emergency Department
por: Aldawsari, Faleh M, et al.
Publicado: (2021)

Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4
por: Al Ashgar, Hamad, et al.
Publicado: (2009)

The Association of Toll-Like Receptor 4 Polymorphism with Hepatitis C Virus Infection in Saudi Arabian Patients
por: Al-Qahtani, Ahmed A., et al.
Publicado: (2014)

N-Butyl-2-Cyanoacrylate (Histoacryl) Complication: A Case Report
por: Al Ashgar, Hamad, et al.
Publicado: (2006)

Breastfeeding practice and knowledge among women attending primary health-care centers in Riyadh 2016
por: Al-Mutairi, Norah Faleh, et al.
Publicado: (2017)

Efficacy of ursodeoxycholic acid for primary biliary cholangitis: Experience from a tertiary care centre in Saudi Arabia
por: AlWabel, Ahmed H, et al.
Publicado: (2022)

Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and Kuwait
por: Sanai, Faisal M., et al.
Publicado: (2021)

Genetic variability of the core protein in hepatitis C virus genotype 4 in Saudi Arabian patients and its implication on pegylated interferon and ribavirin therapy
por: Alhamlan, Fatimah S, et al.
Publicado: (2014)

Saudi Association for the Study of Liver diseases and Transplantation position statement on the hepatology workforce in Saudi Arabia
por: Al-Judaibi, Bandar, et al.
Publicado: (2022)

Sustained Virologic Response to Peginterferon α-2a and Ribavirin in 335 Patients with Chronic Hepatitis C: A Tertiary Care Center Experience
por: Al Ashgar, Hamad, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_h4gg6cu29vum9s9pqtm8h3pcmt